Ameritas Investment Partners’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-3,058
| Closed | -$147K | – | 3244 |
|
2020
Q1 | $147K | Hold |
3,058
| – | – | 0.01% | 1064 |
|
2019
Q4 | $144K | Buy |
3,058
+358
| +13% | +$16.9K | 0.01% | 1296 |
|
2019
Q3 | $64K | Hold |
2,700
| – | – | ﹤0.01% | 1743 |
|
2019
Q2 | $81K | Buy |
2,700
+1,149
| +74% | +$34.5K | ﹤0.01% | 1637 |
|
2019
Q1 | $35K | Buy |
1,551
+356
| +30% | +$8.03K | ﹤0.01% | 2086 |
|
2018
Q4 | $22K | Buy |
1,195
+480
| +67% | +$8.84K | ﹤0.01% | 2298 |
|
2018
Q3 | $13K | Hold |
715
| – | – | ﹤0.01% | 2748 |
|
2018
Q2 | $7K | Hold |
715
| – | – | ﹤0.01% | 2909 |
|
2018
Q1 | $4K | Hold |
715
| – | – | ﹤0.01% | 2890 |
|
2017
Q4 | $6K | Hold |
715
| – | – | ﹤0.01% | 2856 |
|
2017
Q3 | $10K | Hold |
715
| – | – | ﹤0.01% | 2795 |
|
2017
Q2 | $13K | Hold |
715
| – | – | ﹤0.01% | 2722 |
|
2017
Q1 | $15K | Buy |
+715
| New | +$15K | ﹤0.01% | 2563 |
|